Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life

International Journal of Cardiology

Volumn 222, Issue , 2016, Pages 41-46

  Bekfani, Tarek ^a,b   Pellicori, Pierpaolo ^c   Morris, Daniel A ^a   Ebner, Nicole ^a,d   Valentova, Miroslava ^d,e   Steinbeck, Lisa ^a   Wachter, Rolf ^d   Elsner, Sebastian ^a   Sliziuk, Veronika ^a   Schefold, Joerg C ^f   Sandek, Anja ^d   Doehner, Wolfram ^a   Cleland, John G ^c   Lainscak, Mitja ^g   Anker, Stefan D ^d   von Haehling, Stephan ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF HULL   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Physics and Informatics   (Slovakia)

^f UNIVERSITY OF BERN   (Switzerland)

^g University of Golnik   (Slovenia)

Author keywords

Exercise capacity; Heart failure with preserved ejection fraction; Muscle wasting; Quality of life; Sarcopenia

Indexed keywords

AGED; ARM MUSCLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; ENGLAND; EXERCISE; EXERCISE TEST; FEMALE; GERMANY; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; LEG MUSCLE; MALE; MUSCLE MASS; MUSCLE STRENGTH; OBSERVATIONAL STUDY; OUTPATIENT; OXYGEN CONSUMPTION; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SARCOPENIA; SLOVENIA; CLINICAL TRIAL; COMORBIDITY; EUROPE; EXERCISE TOLERANCE; HEART FAILURE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; WALK TEST;

AGED; COMORBIDITY; ECHOCARDIOGRAPHY; EUROPE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PREVALENCE; QUALITY OF LIFE; SARCOPENIA; SEVERITY OF ILLNESS INDEX; WALK TEST;

EID: 84979573847     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.135     Document Type: Article

References (42)

1. [1] Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L., Redfield, M.M., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355 (2006), 251–259.
2. [2] Wachter, R., Edelmann, F., Diagnosis of heart failure with preserved ejection fraction. Heart Fail. Clin., 10, 2014, 399-06.
3. [3] Haykowsky, M.J., Brubaker, P.H., John, J.M., Stewart, K.P., Morgan, T.M., Kitzman, D.W., Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J. Am. Coll. Cardiol. 58 (2011), 265–274.
4. [4] Borlaug, B.A., Melenovsky, V., Russell, S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114 (2006), 2138–2147.
5. [5] Maeder, M.T., Thompson, B.R., Brunner-La Rocca, H.P., Kaye, D.M., Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J. Am. Coll. Cardiol. 56 (2010), 855–863.
6. [6] Pellicori, P., Kallvikbacka-Bennett, A., Khaleva, O., et al. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?. Int. J. Cardiovasc. Imaging 30 (2014), 69–79.
7. [7] Kitzman, D.W., Higginbotham, M.B., Cobb, F.R., Sheikh, K.H., Sullivan, M.J., Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank–Starling mechanism. J. Am. Coll. Cardiol. 17 (1991), 1065–1072.
8. [8] Katz, S.D., Maskin, C., Jondeau, G., Cocke, T., Berkowitz, R., LeJemtel, T., Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J. Appl. Physiol. 88 (2000), 2138–2142.
9. [9] Haykowsky, M.J., Brubaker, P.H., Morgan, T.M., Kritchevsky, S., Eggebeen, J., Kitzman, D.W., Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J. Gerontol. A Biol. Sci. Med. Sci. 68 (2013), 968–975.
10. [10] Fülster, S., Tacke, M., Sandek, A., et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur. Heart J. 34 (2013), 512–519.
11. [11] Edelmann, F., Gelbrich, G., Düngen, H.D., et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J. Am. Coll. Cardiol. 58 (2011), 1780–1791.
12. [12] von Haehling, S., Morley, J.E., Anker, S.D., An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J. Cachex. Sarcopenia Muscle 1 (2010), 129–133.
13. [13] Abellan van Kan, G., Epidemiology and consequences of sarcopenia. J. Nutr. Health Aging 13 (2009), 708–712.
14. [14] Evans, W., Functional and metabolic consequences of sarcopenia. J. Nutr., 127, 1997, 998-003.
15. [15] Rosenberg, I.H., Sarcopenia: origins and clinical relevance. J. Nutr. 127 (1997), 990–991.
16. [16] Morley, J.E., Kim, M.J., Haren, M.T., Kevorkian, R., Banks, W.A., Frailty and the aging male. Aging Male 8 (2005), 135–140.
17. [17] Morley, J.E., Anker, S.D., von Haehling, S., Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014. J. Cachex. Sarcopenia Muscle 5 (2014), 253–259.
18. [18] Ponikowski, P., Voors, A.A., Anker, S.D., et al., on behalf of the Authors/Task Force Members and Document Reviewers, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J., 2016 (in press).
19. [19] Anker, S.D., Coats, A.J.S., Morley, J.E., et al. Muscle wasting disease: a proposal for a new disease classification. J. Cachex. Sarcopenia Muscle 5 (2014), 1–3.
20. [20] von Haehling, S., Lainscak, M., Doehner, W., et al. Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J. Cachex. Sarcopenia Muscle 1 (2010), 187–194.
21. [21] Paulus, W.J., Tschöpe, C., Sanderson, J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28 (2007), 2539–2550.
22. [22] Nagueh, S.F., Appleton, C.P., Gillebert, T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr. 10 (2009), 165–193.
23. [23] Heymsfield, S.B., Smith, R., Aulet, M., et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am. J. Clin. Nutr. 52 (1990), 214–218.
24. [24] Pietrobelli, A., Formica, C., Wang, Z., Heymsfield, S.B., Dual-energy X-ray absorptiometry body composition model: review of physical concepts. Am. J. Phys. 271 (1996), 941–951.
25. [25] Morley, J.E., Abbatecola, A.M., Argiles, J.M., et al. Sarcopenia with limited mobility: an international consensus. J. Am. Med. Dir. Assoc. 12 (2011), 403–409.
26. [26] Gallagher, D., Visser, M., De Meersman, R.E., et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J. Appl. Physiol. 83 (1997), 229–239.
27. [27] Baumgartner, R.N., Koehler, K.M., Gallagher, D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147 (1998), 755–763.
28. [28] Bruce, R.A., Blackmon, J.R., Jones, J.W., Strait, G., Exercise testing in adult normal subjects and cardiac patients. Pediatrics 32 (1963), 742–756.
29. [29] Naughton, J., Sevellus, G., Balke, B., Physiologic responses of normal and pathologic subjects to a modified work capacity test. J. Sports Med., 31, 1963, 201.
30. [30] Rabin, R., de Charro, F., EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 33 (2001), 337–343.
31. [31] Kind, P., Hardman, G., Macran, S., UK population norms for EQ-SD. York Centre for Health Economics Discussion Paper, Nov 1999, 172.
32. [32] Dyer, M.T.D., Goldsmith, K.A., Sharples, L.S., Buxton, M.J., A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual. Life Outcomes, 8, 2010, 13.
33. [33] Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D.R., Harris, T.B., Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos. Int. 21 (2010), 543–559.
34. [34] Von Haehling, S., The wasting continuum in heart failure: from sarcopenia to cachexia. Proc. Nutr. Soc. 12 (2015), 1–11.
35. [35] Jones, S.E., Maddocks, M., Kon, S.S., et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70 (2015), 213–218.
36. [36] Cesari, M., Pahor, M., Target population for clinical trials on sarcopenia. J. Nutr. Health Aging 12 (2008), 470–478.
37. [37] Rolland, Y., Czerwinski, S., Abellan Van Kan, G., et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging 12 (2008), 433–450.
38. [38] Schaap, L.A., Pluijm, S.M., Deeg, D.J., Visser, M., Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med., 119, 2006, 526.e9-17.
39. [39] Kim, T.N., Park, M.S., Yang, S.J., et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33 (2010), 1497–1499.
40. [40] Morley, J.E., von Haehling, S., Anker, S.D., Are we closer to having drugs to treat muscle wasting disease?. J. Cachex. Sarcopenia Muscle 5 (2014), 83–87.
41. [41] Piepoli, M.F., Binno, S., Corrà, U., et al. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. Eur. J. Heart Fail. 17 (2015), 631–638.
42. [42] von Haehling, S., The muscle in dire straits: mechanisms of wasting in heart failure. Circulation 125 (2012), 2686–2688.